Melanoma/Skin Cancer

Top Story

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs
February 8, 2016

Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent affordable generic cancer drugs from entering the market, according to a forum article published in Blood.

These tactics also have led to an increase in drug prices so that, if available, generics can cost nearly as much as the branded product.

In the Journals

Artificial white light as effective as daylight photodynamic therapy for actinic keratosis

February 5, 2016
Artificial white light photodynamic therapy was as effective and tolerated as daylight photodynamic therapy in men with actinic keratosis, according to study results…
In the JournalsPerspective

ASCO: Immunotherapy is ‘Cancer Advance of the Year’

February 4, 2016
ASCO has named progress in immunotherapy for melanoma and other malignancies as the top cancer advance of the year, according to “Clinical Cancer Advances 2016…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and emphasize the importance…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Meeting News CoverageVideo

VIDEO: Patient reported-outcomes on QOL, depression relating to skin cancer, treatment

October 21, 2015
More »
Featured
CME

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
In the Journals

Artificial white light as effective as daylight photodynamic therapy for actinic keratosis

February 5, 2016
Artificial white light photodynamic therapy was as effective and tolerated as daylight photodynamic therapy in men with actinic keratosis, according…
In the JournalsPerspective

ASCO: Immunotherapy is ‘Cancer Advance of the Year’

February 4, 2016
ASCO has named progress in immunotherapy for melanoma and other malignancies as the top cancer advance of the year, according to “Clinical…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…
At IssueVideo

VIDEO: Combination immunotherapy promising, but questions remain

February 2, 2016
HemOnc Today melanoma section editor Sanjiv S. Agarwala, MD, chief of medical oncology and hematology for St. Luke’s University Hospital &…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
FDA News

FDA grants orphan drug designation to IMCgp100 for uveal melanoma

February 1, 2016
The FDA granted orphan drug designation to IMCgp100 for the treatment of uveal melanoma.IMCgp100 (Immunocore) is part of a class of bispecific…
In the Journals

Sirolimus use in solid-organ transplant recipients lowered risk of subsequent skin cancer

January 29, 2016
Solid-organ transplant recipients who took sirolimus after developing posttransplant cancer had a lower risk for subsequent skin cancer, according to…
In the JournalsPerspective

Indoor tanning likely factor in melanoma diagnosis among younger women

January 28, 2016
Younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, which was particularly true for women in their 20s…
In the Journals

Bankruptcy increases risk for cancer mortality

January 28, 2016
Filing for bankruptcy protection after a cancer diagnosis appeared associated with an increased risk for death, according to the results of a…
More Headlines »
morganatic-roan